NEPH

Nephros Inc.

4.17

USD

-0.21

-4.69%

Sep 22, 15:59 UTC -4

Closed

Pre-Market

4.12

-0.05

-1.32%

Nephros Inc. Profile

About

Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the clinical and financial needs of the treatment provider.

Info & Links

CEO

Robert Banks

Headquarters

380 LACKAWANNA PLACE
SOUTH ORANGE, NJ 07079, UNITED STATES

Auditor

Baker Tilly US, LLP

Share holders

Employees

Nephros Inc. Statistics

Valuation Measures

Market Capitalization²

44.69M

Enterprise Value

39.99M

Enterprise Value/EBITDA(ttm)

22.68

Price to Earnings Ratio(ttm)

39.18

Price to Sales(ttm)

2.26

Price to Book(mrq)

3.91

Price to Cash(ytd)

34.36

Profitability

Gross Margin(ttm)

60.98%

Operating Margin(ttm)

5.48%

Profit Margin(ttm)

7.74%

Return on Equity(ttm)

10.60%

Return on Invested Capital(ttm)

15.29%

Return on Assets(ttm)

8.05%

Income Statement

Revenue(ttm)

20.72M

Revenue Per Share(ttm)

1.91

Gross Profit(ttm)

12.70M

EBITDA(ttm)³

1.76M

Net Income Available to Common(ttm)

1.74M

Diluted EPS(ttm)

0.16

Share Statistics

Beta (5Y Monthly)

1.55

52-Week Change

-3.25%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

10.86M

Dividend Yield

0.00%

Float⁴

10.13M

% Held by Insiders

6.70%

% Held by Institutions

41.10%

Balance Sheet

Total Cash(mrq)

4.70M

Total Cash Per Share(mrq)

0.43

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.07%

Quick Ratio(mrq)

2.71%

Book Value Per Share(mrq)

1.10

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.09

Free Cash Flow(ytd)

-990.00K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.